Page 82 - AN-4-2

Advanced Neurology Brain bioavailability of targeted protein degraders

doi: 10.3390/antib12030043 in cortical blood vessels in mice. Am J Physiol Heart Circ
Physiol. 2012;302(7):H1367-H1377.
100. Jones AR, Shusta EV. Blood-brain barrier transport
of therapeutics via receptor-mediation. Pharm Res. doi: 10.1152/ajpheart.00417.2011
2007;24(9):1759-1771.
111. Helms HCC, Kristensen M, Saaby L, Fricker G, Brodin B.
doi: 10.1007/s11095-007-9379-0 Drug delivery strategies to overcome the blood-brain barrier
101. Yu YJ, Watts RJ. Developing therapeutic antibodies (BBB). Handb Exp Pharmacol. 2022;273:151-183.
for neurodegenerative disease. Neurotherapeutics. doi: 10.1007/164_2020_403
2013;10(3):459-472.
112. Sweeney PW, Walker-Samuel S, Shipley RJ. Insights
doi: 10.1007/s13311-013-0187-4 into cerebral haemodynamics and oxygenation utilising
102. Fishman JB, Rubin JB, Handrahan JV, Connor JR, Fine RE. in vivo mural cell imaging and mathematical modelling. Sci
Receptor-mediated transcytosis of transferrin across the Rep. 2018;8(1):1373.
blood-brain barrier. J Neurosci Res. 1987;18(2):299-304. doi: 10.1038/s41598-017-19086-z
doi: 10.1002/jnr.490180206 113. de Lange ECM. The physiological characteristics and
103. Lichota J, Skjørringe T, Thomsen LB, Moos T. transcytosis mechanisms of the blood-brain barrier (BBB).
Macromolecular drug transport into the brain using targeted Curr Pharm Biotechnol. 2012;13(12):2319-2327.
therapy. J Neurochem. 2010;113(1):1-13. doi: 10.2174/138920112803341860
doi: 10.1111/j.1471-4159.2009.06544.x 114. Bickel U, Yoshikawa T, Pardridge WM. Delivery of peptides
104. van Gelder W, Huijskes-Heins MI, van Dijk JP, Cleton- and proteins through the blood-brain barrier. Adv Drug
Soeteman MI, van Eijk HG. Quantification of different Deliv Rev. 2001;46(1-3):247-279.
transferrin receptor pools in primary cultures of porcine doi: 10.1016/s0169-409x(00)00139-3
blood-brain barrier endothelial cells. J Neurochem.
1995;64(6):2708-2715. 115. Thöle M, Nobmann S, Huwyler J, Bartmann A, Fricker G.
Uptake of cationized albumin coupled liposomes by cultured
doi: 10.1046/j.1471-4159.1995.64062708.x
porcine brain microvessel endothelial cells and intact brain
105. Johnsen KB, Burkhart A, Thomsen LB, Andresen TL, capillaries. J Drug Target. 2002;10(4):337-344.
Moos T. Targeting the transferrin receptor for brain drug doi: 10.1080/10611860290031840
delivery. Prog Neurobiol. 2019;181:101665.
116. Patching SG. Glucose transporters at the blood-brain
doi: 10.1016/j.pneurobio.2019.101665
barrier: Function, regulation and gateways for drug delivery.
106. Niewoehner J, Bohrmann B, Collin L, et al. Increased brain Mol Neurobiol. 2017;54(2):1046-1077.
penetration and potency of a therapeutic antibody using a
monovalent molecular shuttle. Neuron. 2014;81(1):49-60. doi: 10.1007/s12035-015-9672-6.
doi: 10.1016/j.neuron.2013.10.061 117. Nadal A, Fuentes E, Pastor J, McNaughton PA. Plasma
albumin is a potent trigger of calcium signals and
107. Yu YJ, Zhang Y, Kenrick M, et al. Boosting brain uptake DNA synthesis in astrocytes. Proc Natl Acad Sci USA.
of a therapeutic antibody by reducing its affinity for a 1995;92(5):1426-1430.
transcytosis target. Sci Transl Med. 2011;3(84):84ra44.
doi: 10.1073/pnas.92.5.1426
doi: 10.1126/scitranslmed.3002230
118. Dvorak AM, Feng D. The vesiculo-vacuolar organelle
108. Ullman JC, Arguello A, Getz JA, et al. Brain delivery (VVO). A new endothelial cell permeability organelle.
and activity of a lysosomal enzyme using a blood- J Histochem Cytochem. 2001;49(4):419-432.
brain barrier transport vehicle in mice. Sci Transl Med.
2020;12(545):eaay1163. doi: 10.1177/002215540104900401
doi: 10.1126/scitranslmed.aay1163 119. Komarova Y, Malik AB. Regulation of endothelial
permeability via paracellular and transcellular transport
109. Kariolis MS, Wells RC, Getz JA, et al. Brain delivery of pathways. Annu Rev Physiol. 2010;72:463-493.
therapeutic proteins using an Fc fragment blood-brain
barrier transport vehicle in mice and monkeys. Sci Transl doi: 10.1146/annurev-physiol-021909-135833
Med. 2020;12(545):eaay1359. 120. Schnitzer JE, Oh P. Albondin-mediated capillary
doi: 10.1126/scitranslmed.aay1359 permeability to albumin. Differential role of receptors in
endothelial transcytosis and endocytosis of native and
110. Santisakultarm TP, Cornelius NR, Nishimura N, et al.
In-vivo two-photon excited fluorescence microscopy reveals modified albumins. J Biol Chem. 1994;269(8):6072-6082.
cardiac-and respiration-dependent pulsatile blood flow doi: 10.1016/S0021-9258(17)37571-3

Volume 4 Issue 2 (2025) 76 doi: 10.36922/an.5140